• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Design and analysis of intra-subject variability in cross-over experiments.

作者信息

Chinchilli V M, Esinhart J D

机构信息

Center for Biostatistics & Epidemiology, College of Medicine, Pennsylvania State University, Hershey 17033-0850, USA.

出版信息

Stat Med. 1996 Aug 15;15(15):1619-34. doi: 10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N.

DOI:10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N
PMID:8858786
Abstract

Recently, interest has grown in the development of inferential techniques to compare treatment variabilities in the setting of a cross-over experiment. In particular, comparison of treatments with respect to intra-subject variability has greater interest than has inter-subject variability. We begin with a presentation of a general approach for statistical inference within a cross-over design. We discuss three different statistical models where model choice depends on the design and assumptions about carry-over effects. Each model incorporates t-variate random subject effects, where t is the number of treatments. We develop maximum likelihood (ML) and restricted maximum likelihood (REML) approaches to derive parameter estimators and we consider a special case in which closed-form expressions for the variance component estimators are available. Finally, we illustrate the methodologies with the analysis of data from three examples.

摘要

相似文献

1
Design and analysis of intra-subject variability in cross-over experiments.
Stat Med. 1996 Aug 15;15(15):1619-34. doi: 10.1002/(SICI)1097-0258(19960815)15:15<1619::AID-SIM326>3.0.CO;2-N.
2
Randomization as a basis for inference in noninferiority trials.随机化作为非劣效性试验推断的基础。
Pharm Stat. 2006 Oct-Dec;5(4):265-71. doi: 10.1002/pst.214.
3
Analysis of multiple-dose bioequivalence studies.
J Biopharm Stat. 1994 Nov;4(3):423-35. doi: 10.1080/10543409408835093.
4
Small sample inference for fixed effects from restricted maximum likelihood.基于限制最大似然法的固定效应小样本推断
Biometrics. 1997 Sep;53(3):983-97.
5
Tests for inter-subject and total variabilities under crossover designs.交叉设计下受试者间变异性和总变异性的检验。
J Biopharm Stat. 2002 Nov;12(4):503-34. doi: 10.1081/BIP-120016233.
6
Likelihood inference on the relative risk in split-cluster designs.分裂型群组设计中相对风险的似然推断。
Clin Trials. 2011 Feb;8(1):37-47. doi: 10.1177/1740774510392254.
7
A simple analysis of a simple crossover trial with a dichotomous outcome measure.简单交叉试验二分类结局测量指标的简单分析。
Stat Med. 2010 Jan 30;29(2):193-8. doi: 10.1002/sim.3771.
8
A three-step procedure for assessing bioequivalence in the general mixed model framework.在一般混合模型框架下评估生物等效性的三步程序。
Stat Med. 1996 Dec 30;15(24):2635-55. doi: 10.1002/(SICI)1097-0258(19961230)15:24<2635::AID-SIM444>3.0.CO;2-X.
9
Sample size calculation for the Power Model for dose proportionality studies.剂量比例研究的功效模型的样本量计算。
Pharm Stat. 2007 Jan-Mar;6(1):35-41. doi: 10.1002/pst.241.
10
CrossOver: an algorithm for the construction of efficient cross-over designs.交叉设计:一种构建高效交叉设计的算法。
Stat Med. 2004 Sep 15;23(17):2645-58. doi: 10.1002/sim.1860.

引用本文的文献

1
A randomized trial to evaluate the impact of Singapore's forthcoming Nutri-grade front-of-pack beverage label on food and beverage purchases.一项评价新加坡即将推出的 Nutri-grade 营养标签对食品饮料购买影响的随机试验。
Int J Behav Nutr Phys Act. 2023 Feb 15;20(1):18. doi: 10.1186/s12966-023-01422-4.
2
Modeling the dose effects of soybean oil in salad dressing on carotenoid and fat-soluble vitamin bioavailability in salad vegetables.模拟沙拉酱中大豆油剂量对沙拉蔬菜中类胡萝卜素和脂溶性维生素生物利用度的影响。
Am J Clin Nutr. 2017 Oct;106(4):1041-1051. doi: 10.3945/ajcn.117.153635. Epub 2017 Aug 16.
3
Bioequivalence testing by statistical shape analysis.
通过统计形状分析进行生物等效性测试。
J Pharmacokinet Pharmacodyn. 2007 Aug;34(4):451-84. doi: 10.1007/s10928-007-9055-3. Epub 2007 Jun 7.
4
A matched crossover design for clinical trials.一种用于临床试验的配对交叉设计。
Contemp Clin Trials. 2007 Sep;28(5):638-46. doi: 10.1016/j.cct.2007.02.003. Epub 2007 Feb 27.
5
Variability in the bioavailability of phenytoin capsules in males and females.男性和女性中苯妥英胶囊生物利用度的变异性。
Pharm Res. 2001 Mar;18(3):394-7. doi: 10.1023/a:1011075502215.
6
Bioequivalence of methylphenidate immediate-release tablets using a replicated study design to characterize intrasubject variability.采用重复研究设计表征个体内变异性的哌甲酯速释片生物等效性研究
Pharm Res. 2000 Apr;17(4):381-4. doi: 10.1023/a:1007560500301.
7
Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration.生物等效性中受试者与制剂的相互作用:概念和统计学问题。美国食品药品监督管理局人群/个体生物等效性工作组。美国食品药品监督管理局。
Pharm Res. 2000 Apr;17(4):375-80. doi: 10.1023/a:1007508516231.